2 December, 2022 - Paris, France
The 5th edition of the Hybrid AF Therapies Summit is heading to Paris in 2022! Join your colleagues on 2nd December for a program covering AF treatment with Hybrid AF Therapies.
The program will explore how Hybrid AF Therapies are shaping new standards of care in atrial fibrillation advanced treatment.
Led by an international panel of speakers, the event will include sessions and roundtables on latest clinical trial results, best practices, patient selection criteria and procedural considerations.
Electrophysiologists and Cardiac Surgeons who are interested in developing a Hybrid AF program, or have already started it and would like to further advance their expertise through discussions with peers.
The program commences on 2nd December from 09:00 until 17:00 CET
– Pathophysiology and treatment options for persistent and long-standing persistent AF
– Principles and techniques for epicardial ablation and LAA exclusion
– Review of the latest clinical data
– Expert panel discussions
– Opportunities and challenges of developing a Hybrid AF program
– Real-world case debate
Venue: Institut Mutualiste Montsouris
42 Bd Jourdan
Hotel bookings will be allocated on an individual basis and you will receive a reservation confirmation by email. Please check your travel details tab in your AF Connect dashboard for your details.
The “Save the Date” flyer is available for download.